NFG
ONC

Next Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Next Financial Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$9K Buy
34
+13
+62% +$4.39K ﹤0.01% 2244
2021
Q3 		$8K Buy
+21
New +$6.87K ﹤0.01% 2118

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Next Financial Group's ONC Position: Q4 2021 in Review

Next Financial Group increased its BeOne Medicines Ltd (ONC) stake by 62% in Q4 2021, buying an estimated $4.39K and bringing the position to 34 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

Next Financial Group first reported a position in ONC in Q3 2021 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold ONC as of Q4 2021.

  • Next Financial Group held 34 shares of BeOne Medicines Ltd worth $9K as of Q4 2021.
  • Next Financial Group bought 13 BeOne Medicines Ltd shares in Q4 2021, an estimated $4.39K.
  • BeOne Medicines Ltd made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2244 holding.
  • Next Financial Group first reported a position in BeOne Medicines Ltd in Q3 2021 and has held it in 2 quarters since.
  • 262 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.